Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=61147231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017000601(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb CofiledCriticalBristol Myers Squibb Co
Priority to CL2017000601ApriorityCriticalpatent/CL2017000601A1/en
Publication of CL2017000601A1publicationCriticalpatent/CL2017000601A1/en
<p>LA PRESENTE DESCRIPCIÓN PROPORCIONA PÉPTIDOS MACROCÍCLICOS NOVEDOSOS QUE INHIBEN LAS INTERACCIONES PROTEÍNA/PROTEÍNA PPD-1/PD-L1 Y PD-L1/CD80, Y POR ENDE, SON ÚTILES PARA LA MEJORA DE VARIAS ENFERMEDADES, QUE INCLUYEN EL CÁNCER Y LAS ENFERMEDADES INFECCIOSAS.</p><p> THIS DESCRIPTION PROVIDES NOVELTY MACROCYCLIC PEPTIDES THAT INHIBIT THE PROTEIN / PROTEIN INTERACTIONS PPD-1 / PD-L1 AND PD-L1 / CD80, AND THEREFORE, ARE USEFUL FOR THE IMPROVEMENT OF VARIOUS DISEASES, WHICH INCLUDE AND C INFECTIOUS DISEASES. </p>
CL2017000601A2017-03-102017-03-10
Macrocyclic inhibitors of protein / protein programmed death interactions 1 (pd-1) / pd-l1 and cd80 (b7-1) / pd-l1
CL2017000601A1
(en)
MACROCYCLIC INHIBITORS OF THE INTERACTIONS: PROTEIN OF THE SCHEDULED DEATH (PD-1) WITH ITS BIDDING (PD-L1) [INTERACTION PD-1 / PD-L1] AND OF THE DIFFERENTIATION Cumulus 80 (CD80) ALSO KNOWN AS PROTEIN B7-1 WITH LINK 1 OF THE PROGRAMMED DEATH PROTEIN (PD-L1) [CD80 OR B7-1 / PD-L1 INTERACTION]